Partha Anbil 
Engagement Strategy with IHS & IDNs
Clinical pathways are formalized processes of care designed to reduce treatment variability. They can ...
ACOs and IDNs: What’s the Difference and How Can Pharma Engage Them?
Although the concept of Integrated Health Systems (IHSs), aka Integrated Delivery Networks (IDNs), is ...
Value and Impact of Early Commercialization on Drug Development
A new product launch, perhaps the single-most important initiative for a company, is the ...
Overcoming the Institutional Voids to Succeed in Emerging Markets
Pharmaceutical market growth has shifted from the U.S. and Europe toward Asia, South America, ...
A Pharma Marketer’s Guide to Multivariate Analyses
Putt’s Law states, “Technology is dominated by two types of people: Those who understand ...
Examining The Past To Improve Your Brand’s Future
Pharma marketers are always looking for new ways to improve their brand’s commercialization prospects ...
